L. Lönndahl, “Substance P Antagonist Aprepitant Shows no Additive Effect Compared with Standardized Topical Treatment Alone in Patients with Atopic Dermatitis”, Acta Derm Venereol, vol. 98, no. 3, pp. 324–328, Dec. 2017.